Back to directory

Myeloma and AL-Amyloidosis Program

LMU University Hospital Munich (Klinikum der Ludwig-Maximilians-Universitaet Muenchen)

AL Amyloidosis ATTRv ATTRwt AA Amyloidosis 1 Rare Subtype

Contact Information

Primary Contact

Sebastian Theurich

Deputy Director, Professor of Medicine

Activity level

  • Patients per year20
  • New diagnoses per year5

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyOn-site
  • PathologyOn-site
Other specialists
GastroenterologyHepatologyPulmonologyRheumatologyOrthopaedicsGeneticistsGenetic counsellorsNuclear medicine specialistsCardiac imaging specialistsRadiologistsTransplant programme - heartTransplant programme - kidneyTransplant programme - liverAllied health professionals (NP, PA)Palliative carePsychology / counsellingSocial work

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)On-site
  • Amyloid typingThrough network partners
  • Genetic testingOn-site
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site
Partner laboratories

University Heidelberg, Germany: Clinical Cooperation Partner (Amylodosis Center)
University Kiel, Germany: Reference Pathologist
University Tübingen, Germany: Reference Pathologist

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AAYes
Rare subtypes
Localised amyloidosis

Treatment options

  • Chemotherapy (AL)Available on-site
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable on-site
  • Heart transplantAvailable on-site
  • Kidney transplantAvailable on-site
  • Liver transplantAvailable on-site

Patient support services

Services offered
Psychosocial supportSocial workGenetic counsellingNutritional guidance (dietitian)Patient support groupsPalliative care

Networks & telemedicine

  • Telemedicine / virtual consultationNo
  • Part of a formal amyloidosis networkNo
  • Diagnostic services for other organisationsNo
Diagnostic services contact

Last confirmed: 27 March 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.